Bacterial intracellular proteins and enzymes

Bacterial intracellular proteins and enzymes represent a broad category of essential molecules located within the bacterial cytoplasm that facilitate critical life processes such as DNA replication, RNA transcription, protein synthesis, and metabolic pathways [1, 2]. These proteins are the primary targets for several major classes of antibiotics; for instance, fluoroquinolones inhibit DNA gyrase and topoisomerase IV, while macrolides and tetracyclines target the bacterial ribosome to halt protein production [1, 3]. The therapeutic utility of these targets relies on structural differences between bacterial enzymes and their human counterparts, which minimizes host toxicity, though similarities between bacterial and mitochondrial ribosomes can lead to adverse effects [2, 4]. To be effective, drugs must penetrate the bacterial cell envelope to reach these intracellular sites, a process often hindered by efflux pumps or membrane permeability barriers [4]. This category is fundamental to the treatment of bacterial infections, yet it is also the focus of various resistance mechanisms, including target site mutations and enzymatic degradation of the drugs [1, 4].

Other names

Bacterial cytoplasmic proteinsIntracellular bacterial enzymesBacterial metabolic targets

Inhibition of essential intracellular processes including nucleic acid synthesis (DNA/RNA), protein synthesis (ribosomal translation), and metabolic pathways (folate synthesis) [1, 2, 3].